Ignacio Plaza
Director/Board Member at Alxerion Biotech Corp.
Profile
Ignacio Plaza has held director positions at MATba ROFEX SA and Alxerion Biotech Corp.
Ignacio Plaza active positions
| Companies | Position | Start |
|---|---|---|
Alxerion Biotech Corp.
 Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | Director/Board Member | - |
Former positions of Ignacio Plaza
| Companies | Position | End |
|---|---|---|
Rofex SA
 Rofex SA Investment Banks/BrokersFinance MATba ROFEX SA engages in the provision of financial services. The firm specializes in trading securities such as futures and options agreements on agricultural, financial, and other commodities, as well as, interconnection via, spot shares and bonds. The company was founded on November 19, 1909 and is headquartered in Rosario, Argentina. | Director/Board Member | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Rofex SA
Rofex SA Investment Banks/BrokersFinance MATba ROFEX SA engages in the provision of financial services. The firm specializes in trading securities such as futures and options agreements on agricultural, financial, and other commodities, as well as, interconnection via, spot shares and bonds. The company was founded on November 19, 1909 and is headquartered in Rosario, Argentina. | Finance |
Alxerion Biotech Corp.
Alxerion Biotech Corp. Miscellaneous Commercial ServicesCommercial Services Alxerion Biotech Corp. engages in research and development in biotechnology. It provides services to drug delivery and discovery projects by integrating capabilities in Exosome-HTS technologies, in-house screening compounds libraries, animal models, gene therapy and nanocarrier technologies. The company was founded by Mercedes Balcells, Edelman R. Elazer and Javier Pedreño in 2017 and is headquartered in Cambridge, MA. | Commercial Services |
- Stock Market
- Insiders
- Ignacio Plaza
